- Home
- MNY vs PAVM Comparison
MNY vs PAVM Comparison
Compare MNY & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNY | PAVM |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.4M | 41.1M |
| IPO Year | 2023 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MNY | PAVM |
|---|---|---|
| Price | $0.60 | $1.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.50 |
| AVG Volume (30 Days) | ★ 29.8K | 11.0K |
| Earning Date | 12-04-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,000,000.00 |
| Revenue This Year | N/A | $132.39 |
| Revenue Next Year | $17.49 | $263.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.00 |
| 52 Week Low | $0.38 | $0.21 |
| 52 Week High | $1.60 | $43.99 |
Technical Indicators
Market Signals| Indicator | MNY | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 32.78 |
| Support Level | $0.60 | N/A |
| Resistance Level | $0.91 | $6.56 |
| Average True Range (ATR) | 0.02 | 0.21 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 70.56 | 39.45 |
Price Performance
Historical ComparisonAbout MNY MoneyHero Limited
MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.